A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 13,135 followers.

RT @red_faster: "A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy." https://…

RT @red_faster: "A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy." https://…

RT @red_faster: "A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy." https://…

"A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy." https://t.co/6Zu3WVLn0u

RT @g_orl: A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with.. - https://t.co/Ze5QxJXbcO via @_fee…

A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with.. - https://t.co/Ze5QxJXbcO via @_feedspot